This essay is an informative treatise on well-differentiated thyroid cancer and its
management at a creditable institution. There is a considerable amount of dogma in the
treatment approach to differentiated thyroid cancer because, unfortunately, no firm data are
available in terms of randomized and prospective trials on the management of this usually
indolent type of cancer. This is particularly true for the use of radioiodine (13'I)
postoperatively and the extent of the surgical operation (whether a total or partial …